Tumor Cell Therapy Articles & Analysis
11 articles found
The BCL2 gene, short for B-cell lymphoma 2, is a critical regulator of apoptosis, or programmed cell death. ...
Alfa Cytology employs state-of-the-art techniques including isolation, culture, engineering, expansion, and characterization of immune cells and stem cells to develop novel cell therapies. These innovative solutions are grounded in a comprehensive understanding of tumor biology and immune system dynamics, ...
This phenomenon offers a remarkable opportunity in cancer therapy. Tumors often exhibit mutations that can be exploited for targeted treatments. ...
By harnessing the natural capabilities of the immune system, immuno-oncology services are revolutionizing the way we approach cancer treatment, offering novel therapies that are changing the prognosis for many patients. Understanding Immuno-Oncology Immuno-oncology focuses on the interaction between the immune system and cancer cells. Unlike traditional cancer ...
Cell cycle progression is orchestrated by key proteins, including cyclins, cyclin-dependent kinases (CDKs), and tumor suppressors. ...
Through peptide sequencing, we can discover new peptide drugs with specific bioactivity, such as peptide hormones and peptide antibodies, providing powerful tools for targeted therapy. At present, peptide drugs have shown broad application prospects in the treatment of tumors, hepatitis, diabetes, and AIDS.Antibody-Based TherapyAntibodies are proteins produced by ...
This cutting-edge technology holds great potential in treating diseases through targeted drug delivery. CAR-T/CAR-NK Cells Development for Drug Delivery Systems As a groundbreaking advancement in immunotherapy, CAR-T (Chimeric Antigen Receptor T-cell) and CAR-NK (Chimeric Antigen Receptor Natural Killer) cells have shown remarkable success in ...
CARs are able to recognize targets on the surface of tumor cells. Although CAR-T therapy has revolutionized the treatment of hematological diseases such as leukemia and lymphoma, it has not translated into similar success in solid tumors. ...
Normal cells have quality-control mechanisms to ensure that mRNA is correctly transcribed from gene-coding regions in DNA, but tumor cells make frequent transcription mistakes, including adding or cutting out nucleotides to produce mRNA riddled with errors called frameshift mutations. ...
ByCalviri
Why do we need new cell contenders in the CAR field? Well, different CAR immune cells have different advantages and sometimes unique challenges or limitations. So, we began our discussion of alternative CAR-cell types with CAR-NK cells due to their current standing as the most popular alternative CAR-based ...
The proton beam was investigated for cancer cell therapy in the pancreas. Neon ion interaction profiles were compared with the result of the proton beam, which was investigated for nanoscale ion beam interactions. Simulation for the Bragg peak calculation was performed for interactions with a human organ, the pancreas. The results show the absorbed dose and dose equivalent, which vary with the ...